Streetbeat News

Analyst Ratings

NYCB

Wedbush analyst David Chiaverini maintains an Underperform rating on New York Community (NYCB) and lowers the price target from $5 to $3.5.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:34 pm

KYMR

Truist Securities analyst Srikripa Devarakonda maintains a Buy rating on Kymera Therapeutics (KYMR) and raises the price target from $41 to $54.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:33 pm

PRVA

TD Cowen analyst Gary Taylor has maintained an Outperform rating on Privia Health Group (NASDAQ:PRVA) but lowered the price target from $30 to $26.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:32 pm

LSEA

Wedbush analyst Jay McCanless reiterates an Outperform rating on Landsea Homes (NASDAQ:LSEA) and maintains a $16 price target.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:32 pm

JRVR

Truist Securities analyst Mark Hughes maintains a Hold rating on James River Gr Hldgs (JRVR) and lowers the price target from $15 to $11.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:32 pm

IART

Truist Securities analyst Richard Newitter maintains a Hold rating on Integra Lifesciences (IART) and lowers the price target from $46 to $41.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:31 pm

GDRX

Truist Securities analyst Jailendra Singh has maintained a Hold rating on GoodRx Holdings (NASDAQ:GDRX) and increased the price target from $7.5 to $8.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:30 pm

UHS

TD Cowen analyst Gary Taylor has maintained a 'Market Perform' rating on Universal Health Services (UHS) and increased the price target from $140 to $181.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:30 pm

GMS

Truist Securities analyst Keith Hughes has maintained a Hold rating on GMS Inc. (NYSE:GMS) and increased the price target from $72 to $88.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:29 pm

BBY

Truist Securities analyst Scot Ciccarelli has maintained a Hold rating on Best Buy Co (NYSE:BBY) and increased the price target from $68 to $87.

Portfolio Pulse from Benzinga Newsdesk

March 01, 2024 | 1:27 pm